Biopharmaceutical company
Implementation of Home Infusion Therapy Benefit in Medicare CY 2021 Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Policy Issues and Healthcare Common Procedure Coding System (HCPCS) Level II Proposed Rule (CMS-1738-P) and Durable Medical Equipment Fee Schedule Adjustments To Resume the Transitional 50/50 Blended Rates to Provide Relief in Rural Areas and Non-Contiguous Areas; Extension of Timeline for Final Rule Publication (CMS-1687-RCN). 

Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act.
MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas) ALANNA TEMME (LD, Rep. Jon Porter)
Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas LD, Rep. Jon Porter